Intercept Pharmaceuticals (ICPT) Settlement Removes Minor Overhang - BMO Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Intercept Pharma (ICPT) Enters Settlement of Proposed Class Action Suit
May 3, 2016 6:32 AM EDTIntercept Pharma (NASDAQ: ICPT) disclosed the following on Tuesday morning:
Item 8.01 Other Events
On May 2, 2016, Intercept Pharmaceuticals, Inc. (Intercept or the Company) reached an agreement with the lead plaintiff to seek Court approval of a proposed resolution of class action litigation pending against it in the U.S. District Court for the Southern District of New... More
